Evaluate pharma subscription

Ended Definitive Contract Awarded Last action

Contract number
29FTC124C0075
Awardee
Awarding agency
Obligated
$23,000

Award facts

Contract value 100% obligated
$23,000.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
518210 Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services
PSC
DA01 It And Telecom - Business Application/Application Development Support Services (Labor)
Set-aside
No set-aside
Competition
Not Available for Competition · 1 offer Only One Source
Pricing
Firm Fixed Price
Place of performance
Washington, DC 20580, USA

Award details come from SAM.gov/FPDS.

About this award

The U.S. Federal Trade Commission (FTC) awarded a firm fixed-price definitive contract worth $23,000.00 to Evaluate LTD, a for-profit organization, to EVALUATE PHARMA SUBSCRIPTION. The contract has an ultimate completion date of September 26, 2025 and was awarded on September 27, 2024. The contract is not designated as a set-aside.

Quick answers

Who was awarded contract 29FTC124C0075?

29FTC124C0075 was awarded to Evaluate LIMITED by Federal Trade Commission on September 27, 2024.

How much is contract 29FTC124C0075 worth?

The government has obligated $23,000 on 29FTC124C0075.

Was contract 29FTC124C0075 competed?

The extent of competition for 29FTC124C0075 was not available for competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award